Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.0000
+0.3500 (21.21%)
NASDAQ · Last Trade: Dec 26th, 6:03 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors